KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
about
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@ast
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@en
type
label
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@ast
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@en
prefLabel
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@ast
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@en
P2093
P2860
P50
P356
P1476
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
@en
P2093
B Manzanares-Martín
D Rodriguez-Cano
I Perez-Camacho
R Gonzalez
P2860
P2888
P304
P356
10.1038/TPJ.2016.19
P577
2016-03-15T00:00:00Z
P6179
1031440003